Biodesix, Inc. BDSX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Development Services | $10.92M+51.0% | $9.3M+40.6% | $8.92M+104% | $7.97M+83.0% | $7.24M+83.5% | |
| Diagnostic Tests | $85.17M+26.7% | $79.2M+22.4% | $71.25M+18.2% | $68.59M+23.7% | $67.23M+33.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Biodesix, Inc. break its business down?
- Biodesix, Inc. (BDSX) reports revenue by product across 2 parts — Development Services and Diagnostic Tests. Each is extracted from the segment footnotes and tracked over time.
- Where does Biodesix, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Biodesix, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
